Advanced search
Publication Cover
Current Medical Research and Opinion Volume 21, 2005 - Issue 3
Submit an article Journal homepage
71
Views
27
CrossRef citations to date
0
Altmetric
Original Article

A randomized, investigator-masked clinical trial comparing the efficacy and safety of gatifloxacin 0.3% administered BID versus QID for the treatment of acute bacterial conjunctivitis

Richard W. Yee Hermann Eye Center, Houston, TX, USACorrespondence[email protected]
,
Michael Tepedino Cornerstone Research Care, High Point, NC, USA
,
Paula Bernstein Allergan, Inc, Irvine, CA, USA
,
Harold Jensen Allergan, Inc, Irvine, CA, USA
,
Rhett Schiffman Allergan, Inc, Irvine, CA, USA
,
Scott M. Whitcup Allergan, Inc, Irvine, CA, USA
& for the Gatifloxacin BID/QID Study Group show all
Pages 425-431 | Accepted 28 Jan 2005, Published online: 03 Mar 2005

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.